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uMMARY Measles virus (Tanabe strain) was further attenuated by a combination
of adaptation of the \, irus in chorioallantoic membranes of chick embryos, piaque
cloning in chick embryo fibroblast (CEF) cultures and serial passages at low tempera-
ture in CEF. During this further attenuation a variant was obtained which caused
extremely few febrile reactions but had sufficient jinmunogenicity.
In recent clinical tests in 1971, vaccine from this variant of the Tanabe strain of
measles virus caused a febrile reaction in only about 10% of the children \\, ho re-
CGIved a single injection. Of the 401 children who were initially seronegative, 47
had a slight fever one week after vaccination. A neutralizing antibody response was
nets. red in 341 of th. 350 .hikiren (97.4%) f". in wh. in ^erum ^padm, us w, re col-
Iected one month after vaccination, and the geometric mean titer of these sera was
23.6.
INTRODIJCTION
In the last ten years there has been much effort
to attenuate measles virus. In 1960 three
kinds of live attenuated measles virus vaccine
were simultaneously developed in Japan, U. S.
173
A. and U. S. S. R. (Okuno at a1. , 1960; Enders
at a1. , 1960; Sinorodintsev at a1. , 1960).
Schwarz succeeded in further attenuation
of measles virus in 1962 (Schwarz, 1962), and
later further attenuated live measles virus vac-
cines were developed in several countries
(Sinorodintsev at a1. , 1965 ; Hendrickse at al. ,
1966; Chumakov, 1967; Hilleman at al. ,
1968; Ueda at a1. , 1970 a, b). Vaccination
against measles has been done in many coun-
tries, but the further attenuated live measles
virus vaccines used still cause a febrile reaction
in at least about half the children vaccinated.
In our laboratory, work on attenuation of
measles virus has been continued since Okuno
and his group developed an attenuated live
measles virus vaccine. A combination of
methods were used for attenuation of measles
virus (Tanabe strain) : namely, adaptation in
chorioallantoic membranes (CALl) of chick
embryos (Ueda at a1. , 1970 a), PIaque cloning
in chick embryo fibroblast (CEF) cultures
(Takaku er a1. , 1970) and serial passages at low
temperature in CEF. As a result the CAM-
70 further attenuated live measles virus vaccine
was developed in 1971. This caused a febrile
reaction in about 30% of the children given the
vaccine (Okuno at a1. , 1971).
To study the limit of attenuation possible for
measles virus retaining jinmunogenicity, we
selected a temperature-sensitive variant from
the seed virus of the CANT-70 measles virus
vaccine, again by serial PIaque cloning in CEF
cultures at 36 C and passed it in CEF cultures
at low temperature. A preliminary clinical
test with this variant showed that it caused less
febrile reaction in children than the vaccine of
the parent virus. This report presents the
results of clinical tests \\, ith the ITew vaccine
made with the variant.
This variant was passed in CEF cultures 3 times at
26 C to obtain a higher viral yield than that possible
at 36 C. The first test vaccine was made of the
variant at this passage level. A clincial test \\. ith
this revealed that the incidence of a febrile reaction
was less than with the vaccine of the parent, CAM-
70 (Table I, Lot No. K-72)
To examine the genetic stability of the variant, it
was passed 10 to 20 times more in CEF cultures at
26 C. Six test vaccines \\, ere made of the virus at
passage levels of 10 to 20 in CFF cultures
All test vaccines \\. ere Iyophilized in one dose
ampoules, giving over 10' ' Tcl0, ,10.1 inI \\'hen
reconstituted with 0.5 inI of distilled \\, ater.
2. Pacei"ees and rudec, ', I@troll
The vaccinees \\, ere children of 9 months to 6
years of age living in Osaka, Hyogo and Nagano
Prefectures. They \\, ere injected subcLitaneously
in the upper arm with 0.5 inI of one of the vaccines
Vaccinations \\, ere done between July, 1971 and
February, 1972
3. Nei, tinl, ^ing a"1160dy tit, atio, I (A1T)
Serum specimens \\, ere collected on the day of
vaccination and one month later. The neutralizing
antibody titers \\, ere measured by the micro-method
of More au and Furesz (More au and Furesz, 1967)
as modified by one of us (Ueda, 1971). By changing
the strain of challenge \, irus lit the NT from the
Toyoshima strain (Toyoshima at a1. , 1959) to the
Nagahata strain, the period required for reading
neutralizing antibody titers \\, as shortened from one
week to 4 days.
The Nagahata strain of measles virus \\, as isolated
in our laboratory in February, 1971 from a throat
swab of an 18-month old boy, (Koii Nagahata) \\. ith
typical measles in Toyonaka, Osaka using primary
human embryonic kidney, cell (HEK) cultures. it
was passed 3 times more in HEK cultures and then
11 times in FL cell cultures
MATERIALS AND METHODS
I . Pace, }, e
A temperature-sensitive \, ariant \\, as selected from
the seed virus of the CAM. 70 measles virus \, accine
by serial PIaque clonings in CEF cultures at 36 C
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4. SIIrt!ey of chilica/ ledctio, Is
Clinical reactions folio\\, ing \, accination were
surveyed as described in a previous report (Okuno
at a1. , 1971)
RESULTS
I. Clzh, 'cal reacti'0"s
As previously reported (Okuno at a1. , 1971 ;
Ueda at a1. , 1970 b), the test vaccines were also
evaluated clinicalIy by the incidence and grade
of febrile reactions, rash and febrile convul-
As shown in Table I, the test vaccines
all caused febrile reactions in only about 1070
of the vaccinees. Furthermore, fever was
rarely over 39.0 C. The mean time of onset
of a fever was one week after \, accination.
There were no essential differences between
the febrile reactions caused with the various
test vaccines. So, all the results may be sum-
inarized as follows : the new measles virus
vaccine caused a fever of 37.5 C or over in 47
of 401 .hildren (11.7%) and th, fore, w, ^
39.0 C or .re" in ,nly 4 children (1.07, ). Th,
mean maximal body temperature was 38.2 C
and the mean duration of fever was 1.4 days.
Fig. I shows a comparison of the maximal
SIOns.
body temperatures induced by the vaccines
from the new and parent strains. From the
results of field trials conducted in 1969 the
CAM-A4 measles vaccine (Ueda et a1. , 1970 b)
had been evaluated as being similarly attenuated
to the Schwarz strain (Japan Aleasles \;accine
Research Commission, 1970). The CAN1-70
measles vaccine (Okuno at a1. , 1971) is one of
the 2 licensed further attenuated live measles
virus vaccine in Japan. Fig. I shows clearly
that the incidence and the grade of a febrile
reaction with the new vaccine (CANT-Ex) were
much less than those observed with previously
developed vaccines.
A faint rash appeared in 470 of the children,
and febrile convulsions in only one of the 401
children.
TABLE I. Chin'cal ?'enctt'ons and Meut, 'alz^212g antt'body JESpo"ses of childre" recezbz}Ig " CAM-





























































5 x 102 s
a mean days ; b mean maximal temperature (C) ; c mean duration of fever (days) ;
















































































































































37.5 380 38.5 39.0 39.5 over
I 40.0
37.9 38.4 38.9 39.4 39.9
Maximal temperature (C)
FIGURE I. Coinpa, ,'son of the elf, ,1111nti?ie telee"t of
7110xi, ,101 body tenipe, o1/17es 10/10zui, ,g oncei, ,ation toith














2. Are1117nlizi"g antibody I'e$ponse
Neutralizing antibodies (measured as a titer
of one in 2 or over) were elicited in over 96,770
of the children one month after Injection with
0.5 inI of any of the test vaccines. With only
1,500 TclD, , of 10-fold diluted vaccine (Lot
No. K-85), the seroconversion rate was 87.9%
(T^bl, I).
Despite the good seroconversion rate, neu-
tralizing antibody titers were rather low, the
geometric mean titer being only 2' '. Fig. 2
shows the distribution of neutralizing antibody
titers. About 30% of the 350 children showed





FIGURE 2. Dist, ibi, tio?, of 71ei, tm!^^i"g antibody
lite, 's of the 350 children one 7110, ,th after fin"Jimisu-
tio" with CAM-Ex filensles ofri, s o0ccine. Symbols :












During attenuation of measles virus, we ob-
tained a variant which caused a febrile reaction
in only about 10% of the children vaccinated
and which was genetically stable for at least
20 serial passages in CEF cultures. Judging
from the incidence of febrile reactions this van-
ant may well be at the upper limit of attenuation
of measles virus possible for preparation of
attenuated vaccine. So, the newly developed
vaccine of this variant was designated as
" CAM-Ex ", meaning extremely attenuated
CAI\I live measles virus vaccine.
The CAM-Ex measles virus vaccine elicited
neutralizing antibodies in over 9770 of the
children given a single injection. However,
the antibody titers were rather low and about
30% of the children showed a titer of only one
in 4 or less. Because of this, it seems that
several years clinical and serological follow-up
of the vaccinated children is necessary before
this vaccine can be evaluated. But, if the
relatively low antibody titer of the neutralizing
antibodies elicited with this vaccine is found to
10
o
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persist like those with other attenuated live
measles virus vaccines " CALl-Ex " measles
virus vaccine may be the most suitable \, accine
for use in a mass vaccination to eradicate
measles.
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